首页> 外文OA文献 >Evaluation of the Effects of Human Beta-Interferon Scaffold Attachment Region (IFN-SAR) on Expression of Vascular Endothelial Growth Factor-Fc (VEGF-Fc) Fusion Protein Expression in Chinese Hamster Ovary (CHO) Cells
【2h】

Evaluation of the Effects of Human Beta-Interferon Scaffold Attachment Region (IFN-SAR) on Expression of Vascular Endothelial Growth Factor-Fc (VEGF-Fc) Fusion Protein Expression in Chinese Hamster Ovary (CHO) Cells

机译:人β-干扰素支架附着区(IFN-SAR)对中国仓鼠卵巢(CHO)细胞中血管内皮生长因子-FC(VEGF-FC)融合蛋白表达表达的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Recombinant anti-vascular endothelial growth factor (VEGF) monoclonal antibodies and Fc-fusion proteins have been widely used for the effective treatment of retinal neovascular diseases. In this regard, VEGFR-Fc fusions, which act as strong VEGF inhibitors, have been approved for the treatment of age-related macular degeneration (AMD) and diabetic macular edema (DME). Production of monoclonal antibodies and Fc-fusion proteins relies on mammalian host systems such as Chinese hamster ovary (CHO) cells. Application of genomic regulatory elements including scaffold/matrix attachment regions (SAR/MARs) can profoundly affect recombinant protein expression in CHO cells. Methods: To construct the VEGFR-Fc expression vectors, the enhanced green fluorescent protein (EGFP) gene was replaced by the VEGFR-Fc coding sequence in pEGFP-SAR-puro and pEGFP-puro vectors. Recombinant plasmids were transfected to CHO-K1 cells using TurboFect transfection reagent. VEGFR-Fc expression was evaluated in transiently transfected cells as well as stable cell pools and clones using an enzyme-linked immunosorbent assay (ELISA). Results: IFN-SAR showed no significant effect on transient expression of VEGFR-Fc during 72 h of culture. However, a 2.2-fold enhancement in VEGFR-Fc fusion protein titer was observed in IFN-SAR containing stable cell pools. Further evaluation of the VEGFR-Fc expression level in single-cell clones also indicated that clones with the highest VEGFR-Fc expression belonged to the pools transfected with IFN-SAR construct. Conclusion: Our results indicate that the incorporation of IFN-SAR in expression vector can increase the expression of VEGFR-Fc in stable cell pools as well as single-cell clones. In contrast, transient expression of the fusion protein was not affected by IFN-SAR. More studies are needed to investigate the mechanism underlying this effect, including the analysis of mRNA expression and gene copy number in stable cell pools as well as clonal cells.
机译:背景:重组抗血管内皮生长因子(VEGF)的单克隆抗体和Fc融合蛋白已经被广泛地用于有效治疗视网膜新生血管性疾病。在这方面,VEGFR-Fc融合,它作为强大的VEGF抑制剂,已被批准用于与年龄相关性黄斑变性(AMD)和糖尿病性黄斑水肿(DME)的治疗。单克隆抗体和Fc融合蛋白的生产依赖于哺乳动物宿主系统如中国仓鼠卵巢(CHO)细胞。基因组的调控元件,包括支架/基质附着区(SAR / MARS)可以深刻影响在CHO细胞中重组蛋白质的表达中的应用。方法:为了构建VEGFR-Fc表达载体中,增强型绿色荧光蛋白(EGFP)基因通过在质粒pEGFP-SAR-PURO和pEGFP-PURO矢量的VEGFR-Fc的编码序列代替。重组质粒转染到使用TurboFect转染试剂CHO-K1细胞。在瞬时转染细胞,以及稳定细胞池和克隆使用酶联免疫吸附测定(ELISA)VEGFR-Fc表达进行了评价。结果:IFN-SAR表明培养的72小时内对VEGFR-Fc的瞬时表达没有显著效果。然而,在含有稳定细胞池IFN-SAR中观察到VEGFR-Fc融合蛋白滴度2.2倍的增强。在单细胞克隆的VEGFR-Fc表达水平的进一步的评价还表明,具有最高VEGFR-Fc表达克隆属于用IFN-SAR构建体转染的池。结论:我们的结果表明,IFN-SAR的在表达载体中掺入能增加在稳定细胞池以及单细胞克隆VEGFR-Fc的表达。与此相反,该融合蛋白的瞬时表达不影响IFN-SAR。需要更多的研究来调查机构这样的效果基础,包括mRNA表达和基因拷贝数在稳定细胞池以及克隆细胞的分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号